References
- Lukens JN. The thalassemias and related disorders of hemoglobin synthesis. In: Lee GR, Bithell TC, Foerster J, et al. (eds), Wintrobes Clinical Hematology, Philadelphia, PA: Leak & Febiger 1993. p. 1102–45.
- Koliakos G, Papachristou F, Koussi A, Perifanis V, Tsatra I, Souliou E, et al.. Urine biochemical markers of early renal dysfunction are associated with iron overload in beta-thalassaemia. Clin Lab Hematol 2003;25:105–9.
- Orkin SH, Nathan DG. The thalassemia. In: , Nathan D G, Orkin S H, Ginsburg D, Look A T, ed, editors. Nathan and Oski’s heatology of infancy and childhood. Philadelphia, PA: WB Saunders; 2003. p. 842–919.
- Weatherall DJ, Clegy JB. The thalassemia syndromes. 4th ed. Oxford: Blackwell Science; 2001.
- Sumboonnanonda A, Malasit P, Tanphaichitr VS, Ong-ajyooth S, Petrarat S, Vongjirad A. Renal tubular dysfunction in α-thalassemia. Pediatr Nephrol 2003;18:257–60.
- Cianciulli P, Sollecito D, Sorrentino F, Forte L, Gilardi E, Massa A, et al.. Early detection of nephrotoxic effects in thalassemia patients receiving desferrioxamie therapy. Kidney Int 1994;46:467–70.
- Aldudak B, Karabay Bayazit A, Noyan A, Ozel A, Anarat A, Sasmaz I, et al.. Renal function in pediatric patients with beta-thalassemia major. Pediatric Nephrol 2000;15:109–12.
- Oktenli C, Bulueu F. Renal tubular dysfunction in a patient with beta-thalassemia minor. Nephron 2002;92:222–3.
- Hosseini R, Rankohi KE. An improved method for evaluation of nephrotoxicity by assay of urinary beta N-acetyl-d-glucosaminidase (NAG) activity. Toxicol Methods 1997;7:153–76.
- Claudio B, Concett P, Virginia R, Giroloma A, Pietro N, Maria P, et al.. Urinary N-acetyl-β-glucosaminidase exertion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomeralon nephritis. Nephrol Dial Transplant 2002;17:1890–6.
- Dilek E, Denan A, Ilhan B, Eker D, Fatma Z. Urinary N-acetyl-β-d-glucosaminidase (NAG) in lupus nephritis and rheumatoid arthritis. J Clin Lab Anal 2005;19:172–6.
- Basturk T, Altuntas Y, Kurklu A, Aydin L, Eren N, Unsal A. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination. Renal Fail 2006;28:125–8.
- Voskaridou E, Terpos E, Mizhail S, Hantzi E, Anagnostopoulos A, Margeli A, et al.. Early marker of renal dysfunction in patients with sickle cell/β-thalassemia. Kidney Int 2006;69:2037–42.
- Mohkam M, Shamsian SH, shahin N: mohammad. Rend function in patients with beta-thalassemia major. Proc. 10th Iranian Annual Cong. of Nephrology, Dialysis and Transplantation, Urmieh, Iran, May 2006, Urmia University of Medical Sciences. p. 166–7.
- Koren G, Kochavi-Atiya Y, Bentur Y, Olivieri NF. The effects of subcutaneous deferoxamine administration on renal function in thalassemia major. Int J Hematol 1991;54:371–5.
- Price RG. Urinary N-acetyl-β-glucosaminidase as an indicator of renal disease. In: , Dubach U S, Schmidt U, ed, editors. Diagnostic significance of enzymes and proteins in urine. Bern: Hans Huber Publishers; 1979. p.150–3.
- Skinner AM, Addison GM, Price DA. Changes in urinary excretion of creatinine, albumin and N-acetyl-β-d-glucosaminidase with increasing age and maturity in healthy school children. Eur J Pediatr 1996;155:596–602.
- Tomlinson PA, Dalton RN, Hartley B, Haycock GB, Chantler C. Low molecular weight protein excretion in glomerular disease: a comparative analysis. Pediatr Nephrol 1997;11:285–90.
- Fallahzadeh MH, Fallahzadeh MK, Shahriari M, Rastegar S, Derakhshan A, Fallahzadeh MA. Hematuria in patients with beta-thalassemia major. Iran J Kidney Dis 2010;4:133–6.